Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RX-TO-OTC SWITCHES GIVE WHOLESALERS "CLEAR OPPORTUNITY" TO HELP RETAILERS

This article was originally published in The Tan Sheet

Executive Summary

RX-TO-OTC SWITCHES GIVE WHOLESALERS "CLEAR OPPORTUNITY" TO HELP RETAILERS make pricing and merchandising decisions, Dan Raftery, VP at Willard Bishop Consulting, said March 10 at the National Wholesale Druggists Association's marketing conference in Dallas. Raftery explained that Rx-to-OTC switches "are very complex products" requiring "some education by the wholesaler." This education should take the form of not only an "initial commitment," he said, but should also be seen as an "ongoing opportunity" to help retailers. Raftery said that OTC vendors without pharmacies are especially in need of education and support for Rx-to-OTC switch products. "They won't be experienced with prescription products, they won't know what to compare these items to," he explained. Such retailers also will have problems understanding the higher prices of switch products, Raftery indicated. He emphasized, however, that "you cannot use price alone in this area. As a distributor you have the opportunity to provide some value-added [service]." Retailers will need "to understand the complexities and applications" of products that were once behind the counter, Raftery said. Raftery was one of several speakers at the NWDA conference who encouraged wholesalers to help independent drug stores and food markets compete with drug chains, food stores, and mass merchandisers in OTC sales by providing managerial and technical assistance. For example, NWDA Chairman Dwight Steffensen (president and chief operating officer, Bergen Brunswig) said March 10 that drug wholesalers "must collectively design innovative approaches that will ensure that consumer products are available in broad-base distribution in all channels of trade, especially independent pharmacy." He said that "this can only happen when we commit to being players in the consumer products arena." As an example of what wholesalers can do for independent retailers, Steffensen suggested "helping customers implement point-of-sale technology." Industry consultant David Hamacher, D.P. Hamacher & Associates observed that "wholesalers can help encourage technology advancement" by retailers, particularly point-of-sale data gathering, which he said "will be key for independent retailers" in competing with larger rivals. Other areas where Hamacher said wholesalers can assist independent OTC retailers include assisting in inventory management "to cut down on out-of-stock items"; "identifying niches" where a retailer might build an advantage; and providing staff training. Superior customer service "is where [independents] can have an advantage," he maintained. Hamacher and industry consultant Anthony DiNicola, A and D Associates, also pointed to advertising, plan-o-gram development and maintenance; end-cap programs; and seasonal/promotional aisles.

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS081233

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel